A detailed history of New Edge Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 646 shares of CRL stock, worth $120,343. This represents 0.0% of its overall portfolio holdings.

Number of Shares
646
Previous 2,314 72.08%
Holding current value
$120,343
Previous $478,000 73.43%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $313,517 - $409,143
-1,668 Reduced 72.08%
646 $127,000
Q2 2024

Aug 15, 2024

SELL
$206.39 - $268.73 $211,549 - $275,448
-1,025 Reduced 30.7%
2,314 $478,000
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $165,258 - $222,025
812 Added 32.13%
3,339 $904,000
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $77,159 - $112,015
469 Added 22.79%
2,527 $597,000
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $40,054 - $44,827
206 Added 11.12%
2,058 $403,000
Q2 2023

Aug 14, 2023

BUY
$183.71 - $210.25 $16,901 - $19,343
92 Added 5.23%
1,852 $389,000
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $90,955 - $123,202
474 Added 36.86%
1,760 $355,000
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $253,483 - $321,590
1,286 New
1,286 $280,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $682,211 - $966,833
-2,670 Closed
0 $0
Q4 2021

Feb 17, 2022

SELL
$351.38 - $448.68 $574,154 - $733,143
-1,634 Reduced 37.96%
2,670 $1.01 Million
Q3 2021

Oct 29, 2021

BUY
$372.64 - $458.3 $292,895 - $360,223
786 Added 22.34%
4,304 $1.78 Million
Q2 2021

Jul 22, 2021

BUY
$294.17 - $371.65 $1.03 Million - $1.31 Million
3,518 New
3,518 $1.3 Million
Q3 2017

Nov 13, 2017

SELL
$96.72 - $109.26 $2,127 - $2,403
-22 Closed
0 $0
Q2 2017

Aug 16, 2017

BUY
N/A
22
22 $0

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.